Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices

This publication has 17 references indexed in Scilit:

• Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices
  Catheterization and Cardiovascular Interventions, 2002
• Vascular closure devices in patients treated with anticoagulation and iib/iiia receptor inhibitors during percutaneous revascularization
  Journal of the American College of Cardiology, 2002
• Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices
  Journal of the American College of Cardiology, 2001
• Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization
  New England Journal of Medicine, 2001
• Complications of femoral artery closure devices
  Catheterization and Cardiovascular Interventions, 2001
• A direct comparison of tirofiban and abciximab during percutaneous coronary revascularization and stent placement: Rationale and design of the TARGET study
  American Heart Journal, 2000
• Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade
  The American Journal of Cardiology, 2000
• Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND ii) trials
  The American Journal of Cardiology, 2000
• Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring Abciximab (ReoPro)
  Catheterization and Cardiovascular Interventions, 1999
• Immediate arterial hemostasis after cardiac catheterization: Initial experience with a new puncture closure device
  Catheterization and Cardiovascular Diagnosis, 1994